Advertisement
Professionals >> Visit The Body PRO
The Body: The Complete HIV/AIDS Resource
Sign up for free e-mail updates!The Body en Espanol
Please Note: Due to volume considerations, not all questions can be answered. Questions most likely to be answered will be those of general interest to a broad group of visitors to this forum. Questions pertaining to a specific case; requests for diagnosis, medical advice, or second opinion; or requests for opinions about untested alternative therapies will generally not be answered.

Ask the Experts about Facial Wasting
  • E-mail E-Mail
  • Glossary Glossary
Recent AnswersAsk a Question

 

Fat Gain with Sustiva
Aug 2, 2009

I have gained a huge amount of weight /fat whilst on Sustiva, 3TC and Ziagen. I changed the Ziagen for AZT recently and found that the fat gain (everywhere but my face and legs has remained the same). I have tried dieting and some excercise but it is very difficult. Is it sensible to get off Sustiva/Effavirenz for a while and change it with Nevirapine? I am starting to get desperate with this.

Advertisement
   Response from Dr. Pierone

Hello, and thanks for posting.

One consideration for your situation is to change to an integrase inhibitor-based regimen. Raltegravir (Isentress) causes less lipid elevation than Sustiva, so it may also produce less fat gain (although we do not have proof of this yet). Changing Atripla (Sustiva + Truvada) to Isentress + Truvada might be a reasonable first step to take.

AZT would probably just exacerbate the lipodystrophy because of its known propensity to cause mitochondrial toxicity.

My personal view is also that overmedication occurs often in the management of HIV infection. It is not uncommon to see people on a 4 drug regimen when only 3 are necessary. A number of studies have shown that 2 highly active agents work as well, or almost as well as three drugs. There is also a growing body of evidence supporting the use of boosted protease inhibitor monotherapy for treatment of HIV infection. The drug companies are not going to fund these trials because of a potential loss of revenue. Unfortunately, the leadership for HIV research in the United States is dominated by a very conservative group of doctors ("the old white guys") who are not interested in exploring the potential for using fewer medications to control HIV replication.

Good luck!



Want to read more questions and answers on this subject? Our experts have answered many similar questions!



Terms of Use
Please remember that this forum is designed for educational purposes only, and experts are not engaged through this forum in rendering legal or medical advice or professional services. Experts appearing on this page are independent and are solely responsible for editing and fact-checking their material. Neither The Body nor any sponsor is the publisher or speaker of posted visitors' questions or the experts' material.

Questions and messages posted to this forum are not statements of advice, opinion, or information of The Body, Body Health Resources Corporation or any sponsor of this forum. While neither The Body nor Body Health Resources Corporation regularly reviews posted content, we reserve the right to delete, move, or edit postings if we deem it appropriate under the circumstances. Visitors submitting questions remain solely responsible for the content of their messages.

Information provided by experts is general only and should not be used for diagnosing or treating a health problem or a disease, or relied upon as legal or other professional advice. This information is not a substitute for professional advice or care. If you have or suspect you may have a health or legal problem, you should consult your own health care provider or your attorney.

Copyright notice.

Advertisement